Skip to main content
Premium Trial:

Request an Annual Quote

NCI Creates $104M Proteomics Cancer Plan; Taps Five Labs to Evaluate Tools, Methods

This update provides a link to the NCI page that lists the labs participating with the five principal centers.
 
NEW YORK (GenomeWeb News) – The National Cancer Institute today unveiled a $104 million Clinical Proteomic Technologies Initiative for Cancer.
 
NCI awarded a total of $35.5 million in grants over five years to establish a network of five teams for Clinical Proteomic Technology Assessment for Cancer, the agency said. The teams comprise: the Broad Institute of MIT and Harvard; University of California San Francisco/Lawrence Berkeley National Laboratory; Vanderbilt University School of Medicine; Purdue University; and Memorial Sloan-Kettering Cancer Center.
 
Each team will assess measurement technologies for proteins and peptides relevant to clinical cancer research and practice. Specifically, they will assess mass spectrometry and affinity capture platforms and evaluate the performance of various proteomic technology platforms. A list of the teams that comprise each of the five labs can be found here.
 
The NCI said standards will allow researchers conducting cancer-related protein research at different labs to use proteomic technologies and methodologies to directly compare and analyze their work.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.